These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 20172059

  • 1. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM, Oliveira P, Mortara RA, Silveira JF, Bahia D.
    N Biotechnol; 2010 Dec 31; 27(6):837-43. PubMed ID: 20172059
    [Abstract] [Full Text] [Related]

  • 2. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.
    Zhang L, Tarleton RL.
    J Infect Dis; 1999 Aug 31; 180(2):480-6. PubMed ID: 10395865
    [Abstract] [Full Text] [Related]

  • 3. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
    Yoshida N.
    Parasitol Int; 2008 Jun 31; 57(2):105-9. PubMed ID: 18234547
    [Abstract] [Full Text] [Related]

  • 4. Incrimination of Eratyrus cuspidatus (Stal) in the transmission of Chagas' disease by molecular epidemiology analysis of Trypanosoma cruzi isolates from a geographically restricted area in the north of Colombia.
    Dib J, Barnabe C, Tibayrenc M, Triana O.
    Acta Trop; 2009 Sep 31; 111(3):237-42. PubMed ID: 19442641
    [Abstract] [Full Text] [Related]

  • 5. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH, López NC, Ramírez GA, Valck CE, Molina MC, Aguilar L, Rodríguez M, Maldonado I, Martínez R, González C, Troncoso R, Lavandero S, Gingras AR, Schwaeble W, Ferreira A.
    Mol Immunol; 2009 Mar 31; 46(6):1092-9. PubMed ID: 19108895
    [Abstract] [Full Text] [Related]

  • 6. Genomic and proteomic approaches for Chagas' disease: critical analysis of diagnostic methods.
    Huete-Pérez JA, Flores-Obando RE, Ghedin E, Caffrey CR.
    Expert Rev Mol Diagn; 2005 Jul 31; 5(4):521-30. PubMed ID: 16013970
    [Abstract] [Full Text] [Related]

  • 7. Does inhibition of Trypanosoma cruzi key enzymes affect parasite life cycle and geographic distribution?
    Salvati L, Bolognesi M, Ascenzi P.
    IUBMB Life; 2002 Jan 31; 53(1):45-7. PubMed ID: 12018407
    [Abstract] [Full Text] [Related]

  • 8. Probing Trypanosoma cruzi biology with DNA microarrays.
    Burleigh BA.
    Parasitology; 2004 Jan 31; 128 Suppl 1():S3-10. PubMed ID: 16454896
    [Abstract] [Full Text] [Related]

  • 9. Recent developments in the field of Chagas' disease.
    Brener Z.
    Bull World Health Organ; 1982 Jan 31; 60(4):463-73. PubMed ID: 6814776
    [Abstract] [Full Text] [Related]

  • 10. Infection and invasion mechanisms of Trypanosoma cruzi in the congenital transmission of Chagas' disease: a proposal.
    Kemmerling U, Bosco C, Galanti N.
    Biol Res; 2010 Jan 31; 43(3):307-16. PubMed ID: 21249302
    [Abstract] [Full Text] [Related]

  • 11. Trypanosoma cruzi surface mucins: host-dependent coat diversity.
    Buscaglia CA, Campo VA, Frasch AC, Di Noia JM.
    Nat Rev Microbiol; 2006 Mar 31; 4(3):229-36. PubMed ID: 16489349
    [Abstract] [Full Text] [Related]

  • 12. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C, Cortez M, Ferreira D, Yoshida N.
    Int J Parasitol; 2007 Dec 31; 37(14):1609-16. PubMed ID: 17640647
    [Abstract] [Full Text] [Related]

  • 13. An agent-based model for predicting the prevalence of Trypanosoma cruzi I and II in their host and vector populations.
    Devillers H, Lobry JR, Menu F.
    J Theor Biol; 2008 Dec 07; 255(3):307-15. PubMed ID: 18805428
    [Abstract] [Full Text] [Related]

  • 14. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M, de Titto E.
    Acta Physiol Pharmacol Latinoam; 1985 Dec 07; 35(1):1-47. PubMed ID: 2932884
    [Abstract] [Full Text] [Related]

  • 15. Alternative transmission modes for Trypanosoma cruzi.
    Kribs-Zaleta CM.
    Math Biosci Eng; 2010 Jul 07; 7(3):657-73. PubMed ID: 20578791
    [Abstract] [Full Text] [Related]

  • 16. Potential for research on vectors of Chagas' disease.
    Tonn RJ.
    Rev Argent Microbiol; 1988 Jul 07; 20(1 Suppl):1-3. PubMed ID: 3138726
    [No Abstract] [Full Text] [Related]

  • 17. [Pragmatic data and observations related to the epidemiology of Chagas disease].
    Schenone H, Rojas A.
    Bol Chil Parasitol; 1989 Jul 07; 44(3-4):66-86. PubMed ID: 2518649
    [Abstract] [Full Text] [Related]

  • 18. Further genetic characterization of the two Trypanosoma cruzi Berenice strains (Be-62 and Be-78) isolated from the first human case of Chagas disease (Chagas, 1909).
    Cruz RE, Macedo AM, Barnabé C, Freitas JM, Chiari E, Veloso VM, Carneiro CM, Bahia MT, Tafuri WL, Lana M.
    Acta Trop; 2006 Mar 07; 97(3):239-46. PubMed ID: 16343412
    [Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil.
    Carranza JC, Valadares HM, D'Avila DA, Baptista RP, Moreno M, Galvão LM, Chiari E, Sturm NR, Gontijo ED, Macedo AM, Zingales B.
    Int J Parasitol; 2009 Jul 15; 39(9):963-73. PubMed ID: 19504756
    [Abstract] [Full Text] [Related]

  • 20. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas' disease.
    Añez N, Crisante G, da Silva FM, Rojas A, Carrasco H, Umezawa ES, Stolf AM, Ramírez JL, Teixeira MM.
    Trop Med Int Health; 2004 Dec 15; 9(12):1319-26. PubMed ID: 15598264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.